Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.110
-0.040 (-3.48%)
At close: Aug 28, 2026, 4:00 PM EDT
1.116
+0.006 (0.54%)
After-hours: Aug 28, 2026, 5:46 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $68.73 million as of August 28, 2026. Its market cap has decreased by -33.75% in one year.
Market Cap
68.73M
Enterprise Value
-60.62M
1-Year Change
-33.75%
Ranking
Category
Stock Price
$1.11
ChartMarket Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $68.73M, a decrease of -90.68%. That is a compound annual growth rate of -31.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 68.73M | -8.32% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cardiff Oncology | 73.13M |
| MediciNova | 70.63M |
| Spero Therapeutics | 69.88M |
| XBiotech | 69.21M |
| Champions Oncology | 68.50M |
| iBio, Inc. | 67.56M |
| eXoZymes | 66.53M |
| Rein Therapeutics | 65.74M |